You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
贝达药业(300558.SZ)及子公司拟申请不超20亿元融资额度
格隆汇 03-25 21:24

格隆汇 3 月 25日丨贝达药业(300558.SZ)公布,为满足公司业务发展需要,公司及下属子公司卡南吉、贝达诊断、梦工场控股、梦工场科技、贝梦医药、贝药嵊州、Xcovery、医科诺、贝达投资、Xcovery Betta拟申请融资总额不超过20亿元人民币,融资起始期限自此次股东大会审议通过本议案后至2021年度股东大会召开前。具体融资金额将视公司运营资金的实际需求确定,融资金额不超过前述融资额度。针对上述融资,公司与各子公司之间可互相提供担保,担保额度不超过20亿元人民币。为便于公司和子公司向银行申请融资和担保工作顺利进行,提请公司股东大会及董事会授权公司董事长全权代表公司与银行机构签署融资项下的有关法律文件。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account